Indefinite delivery vehicle
GENENTECH INC
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
- PIID
- 75A50118D00036
- Award key
- CONT_IDV_75A50118D00036_7505
- Recipient UEI
- F7F8GZXL7Q93
- Source as of
- Aug 6, 2026
Current award value
—3
Obligated to date
$251,709,3562
Potential with options
$636,607,1003
- Awarding agency
- Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
- Contractor
- GENENTECH INC
- Place of performance
- —
- Set-aside
- No set-aside used
- Pricing
- COST SHARING
- Competition
- —1 offers received
- Period of performance
- Sep 27, 2018 — May 31, 2029
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 27, 2018 | Initial award | $63,393,827.00 | — |
| P00001 | Dec 28, 2018 | M | $0.00 | — |
| P00002 | May 11, 2019 | B | $5,996,083.00 | — |
| P00003 | Sep 17, 2019 | G | $25,000,000.00 | — |
| P00004 | Jan 27, 2020 | B | $7,003,340.00 | — |
| P00005 | Mar 26, 2020 | B | $25,100,000.00 | — |
| P00006 | May 27, 2020 | B | $22,600,000.00 | — |
| P00007 | Dec 21, 2020 | B | $3,000,000.00 | — |
| P00008 | Mar 24, 2021 | G | $3,000,000.00 | — |
| P00009 | Sep 22, 2021 | B | $16,284,147.00 | — |
| P00010 | Jul 26, 2022 | B | $0.00 | — |
| P00011 | Sep 24, 2022 | B | $10,827,095.00 | — |
| P00012 | Jan 13, 2023 | B | $0.00 | — |
| P00013 | Mar 23, 2023 | B | $1,200,000.00 | — |
| P00014 | Jul 17, 2023 | B | $0.00 | — |
| P00015 | Nov 29, 2023 | M | $0.00 | — |
| P00016 | Mar 13, 2024 | B | $12,937,280.00 | — |
| P00017 | Jun 10, 2024 | C | -$8,834,673.70 | — |
| P00018 | Sep 26, 2024 | G | $30,435,786.00 | — |
| P00019 | Oct 11, 2024 | B | $0.00 | — |
| P00020 | Jan 10, 2025 | B | $8,700,000.00 | — |
| P00021 | May 5, 2025 | B | $11,500,000.00 | — |
| P00022 | Jun 16, 2025 | B | $5,557,703.00 | — |
| P00023 | Jun 18, 2025 | M | $0.00 | — |
| P00024 | Oct 1, 2025 | M | $0.00 | — |
| P00025 | Mar 26, 2026 | B | $0.00 | — |
| P00026 | Jul 29, 2026 | SUPPLEMENTAL AGREEME | $8,008,769.00 | — |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| contractor_id | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| current_award_value | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| naics_code | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| potential_award_value | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| psc_code | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| total_obligated | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 27 transaction records parsed from USAspending.gov (FY2026_All_Contracts_Full_20260807_1.csv), retrieved Sep 4, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.